Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China flag China · Delayed Price · Currency is CNY
33.80
-0.06 (-0.18%)
At close: Feb 6, 2026

SHE:301108 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
696.23539.42592.39648.31970.23737.73
Other Revenue
8.038.0330.218.2514.225.29
704.26547.45622.59666.56984.45743.01
Revenue Growth (YoY)
20.74%-12.07%-6.60%-32.29%32.50%141.70%
Cost of Revenue
541.81448.21442.27461.97667.87479.3
Gross Profit
162.4599.24180.32204.59316.58263.72
Selling, General & Admin
58.8551.4655.6838.9129.119.42
Research & Development
26.4320.4822.5225.2936.3827.36
Other Operating Expenses
4.890.560.724.867.133.4
Operating Expenses
102.580.6177.6969.8473.2853.17
Operating Income
59.9518.63102.63134.75243.31210.55
Interest Expense
-1-0.77-1.01-1.86-1.62-0.61
Interest & Investment Income
15.0415.1730.3824.66.052.46
Currency Exchange Gain (Loss)
2.512.511.226.2-6.89-13.47
Other Non Operating Income (Expenses)
-2.010.78-0.23-0.16-0.24-0.18
EBT Excluding Unusual Items
74.4936.32133163.52240.61198.74
Gain (Loss) on Sale of Investments
1.965.59.061.011.2-
Gain (Loss) on Sale of Assets
0.17-0.030.321.150.290.57
Asset Writedown
-18.37-17.49-10.51-11.46-0.42-0.57
Other Unusual Items
4.880.853.137.9510.188.32
Pretax Income
63.1425.15135.01162.16251.85207.06
Income Tax Expense
10.495.9720.4621.231.8127.43
Earnings From Continuing Operations
52.6519.17114.54140.97220.05179.63
Minority Interest in Earnings
0.040.290.66---
Net Income
52.6819.46115.2140.97220.05179.63
Net Income to Common
52.6819.46115.2140.97220.05179.63
Net Income Growth
-6.43%-83.10%-18.28%-35.94%22.50%163.69%
Shares Outstanding (Basic)
1381141141138885
Shares Outstanding (Diluted)
1381141141138885
Shares Change (YoY)
55.65%-0.01%0.14%29.59%2.66%0.12%
EPS (Basic)
0.380.171.011.242.512.11
EPS (Diluted)
0.380.171.011.242.512.11
EPS Growth
-39.88%-83.10%-18.39%-50.57%19.32%163.39%
Free Cash Flow
-233.27-21.11-1.54269.1127.5984.36
Free Cash Flow Per Share
-1.69-0.19-0.012.371.460.99
Dividend Per Share
0.1710.0710.2570.3570.536-
Dividend Growth
-33.33%-72.23%-28.00%-33.34%--
Gross Margin
23.07%18.13%28.96%30.69%32.16%35.49%
Operating Margin
8.51%3.40%16.48%20.21%24.71%28.34%
Profit Margin
7.48%3.56%18.50%21.15%22.35%24.18%
Free Cash Flow Margin
-33.12%-3.86%-0.25%40.37%12.96%11.35%
EBITDA
113.2362.66134.32169.16271.94227.34
EBITDA Margin
16.08%11.45%21.57%25.38%27.62%30.60%
D&A For EBITDA
53.2844.0331.6934.4128.6316.79
EBIT
59.9518.63102.63134.75243.31210.55
EBIT Margin
8.51%3.40%16.48%20.21%24.71%28.34%
Effective Tax Rate
16.62%23.75%15.16%13.07%12.63%13.25%
Revenue as Reported
704.26547.45622.59666.56984.45743.01
Advertising Expenses
-0.060.40.180.050.11
Source: S&P Global Market Intelligence. Standard template. Financial Sources.